Skip to content

Fulgent Genetics, Inc. FLGT Therapeutic Development — Intangible Assets Net Excluding Goodwill

Similar metrics at other companies

Comstock Inc. logo
LODEStrategic Investments — Intangible Assets Net Excluding Goodwill
$0
SS&C Technologies logo
SSNCIntangible Assets Net And Other Assets Excluding Goodwill
$3.96B+4.9%
The Greenbrier Companies logo
GBXIntangible Assets Net And Other Assets Excluding Goodwill
$249.3M-7.2%
Comstock Inc. logo
LODECorporate And Other — Intangible Assets Net Excluding Goodwill
$0
Tempus AI, Inc. logo
TEMIntangible Assets Net Excluding Goodwill Net Of Amortization And Impairment Charges
$330.59M-17.3%
Ralliant Corporation logo
RALIntangible Assets Gross (Excluding Goodwill)
$1.55B+6.2%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.

The official record: Fulgent Genetics, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s therapeutic development — intangible assets net excluding goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s therapeutic development — intangible assets net excluding goodwill?
Fulgent Genetics, Inc. (FLGT) reported therapeutic development — intangible assets net excluding goodwill of $70.73M in Q4 2025.
What does therapeutic development — intangible assets net excluding goodwill mean?
The aggregate net carrying value of all identifiable intangible assets, both finite and indefinite-lived, held by the therapeutic development segment. This metric provides a consolidated view of the segment's non-physical competitive advantages.